An interventional Phase 3, open-label, two-cohort study to investigate the efficacy and safety of fosmanogepix in adult patients with invasive mold infections caused by Aspergillus spp., Fusarium spp., Lomentospora prolificans,Mucorales fungi, or other…

Full Title

An Interventional Phase 3, Open-Label, 2-Cohort Study to Investigate the Efficacy and Safety of Fosmanogepix in Adult Patients with Invasive Mold Infections Caused by Aspergillus spp., Fusarium spp., Lomentospora prolificans, Mucorales fungi, or Other Multidrug Resistant Molds (Advarra IRB)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Yeon Joo Lee’s office at 212-639-8180.